By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Ingredients A-Z > Compound/nutraceutical > Cetyl Myristoleate

Cetyl Myristoleate

GMJ
Last updated: 02/06/2026 18:42
By
Prof. Giorgi Pkhakadze
Share
8 Min Read
SHARE

Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD — GMJ Editorial Board

6 min read|1,103 words

What is Cetyl Myristoleate?

Cetyl myristoleate (CMO) is a fatty acid ester compound that occurs naturally in small amounts in certain animals, particularly mice and sperm whales. It was first discovered in the 1960s by researcher Harry Diehl at the National Institutes of Health. CMO is composed of myristoleic acid (a monounsaturated fatty acid) bound to cetyl alcohol. The compound gained attention when researchers observed that mice appeared to have natural immunity to induced arthritis, which was attributed to the presence of cetyl myristoleate in their tissues.

Today, cetyl myristoleate is primarily produced synthetically for use as a dietary supplement. It’s marketed as a natural anti-inflammatory compound, though the synthetic version is chemically identical to the naturally occurring substance. CMO is typically available in capsule form and is often combined with other joint-supporting nutrients.

Health benefits & uses

Joint health and arthritis (Limited evidence): The primary claimed benefit of cetyl myristoleate is supporting joint health and reducing symptoms of arthritis. Some small studies have suggested potential benefits, but the research remains limited. A few clinical trials have indicated modest improvements in joint function and pain reduction in people with osteoarthritis, though larger, more rigorous studies are needed to establish effectiveness.

Submit Your Paper
GMJ_Submit_Banner

Anti-inflammatory effects (Limited evidence): Some laboratory studies suggest that cetyl myristoleate may have anti-inflammatory properties, potentially helping to reduce inflammatory markers. However, most of this research has been conducted in test tubes or animal models, with limited human clinical data available.

Immune system modulation (Limited evidence): Based on the original observations in mice, some researchers have hypothesized that CMO might help modulate immune system function. However, human studies supporting this claim are lacking, and the mechanisms in humans remain unclear.

How it works

The proposed mechanisms of action for cetyl myristoleate are not fully understood and remain largely theoretical. Researchers suggest that CMO may work by:

Serving as a lubricant for joints and cellular membranes, potentially improving joint mobility and reducing friction. The compound may also influence inflammatory pathways, though the specific mechanisms are unclear. Some theories propose that cetyl myristoleate could modulate immune system responses that contribute to joint inflammation and damage.

Additionally, CMO might affect the production of certain inflammatory mediators or influence the permeability of cell membranes. However, these proposed mechanisms are based primarily on preliminary research and theoretical models rather than established clinical evidence.

Dosage

There is no established recommended daily allowance (RDA) or upper limit (UL) for cetyl myristoleate, as it is not considered an essential nutrient. Typical supplement dosages range from 200-500 mg per day, though some protocols suggest higher amounts for short periods.

Many supplement regimens recommend taking CMO for specific time periods, such as 30-60 days, rather than as ongoing supplementation. Some practitioners suggest divided doses taken with meals to improve absorption.

Due to the limited research on optimal dosing and safety, it’s important to consult with a healthcare provider before beginning supplementation with cetyl myristoleate, especially if you have existing health conditions or take medications.

Food sources

Cetyl myristoleate occurs naturally in very small amounts in certain animal tissues, but these are not practical dietary sources. The compound has been found in:

Mice tissues (where it was first discovered), whale oil, and trace amounts in some fish oils. However, the concentrations in these sources are extremely low and insufficient to provide therapeutic amounts through diet alone.

Practically speaking, there are no significant food sources of cetyl myristoleate that would provide meaningful amounts for supplementation purposes. All commercial CMO supplements use synthetic production methods to create the compound.

Safety & side effects

Cetyl myristoleate appears to be generally well-tolerated in healthy adults when used short-term at typical supplement doses. Reported side effects are typically mild and may include:

Digestive upset, nausea, or diarrhea, particularly when taken on an empty stomach. Some individuals may experience mild skin reactions or allergic responses, though these appear to be rare.

Long-term safety data is limited due to the relatively recent introduction of CMO as a supplement and lack of extensive human studies. The safety of prolonged use or high doses has not been established.

Interactions

Limited information is available regarding specific drug interactions with cetyl myristoleate. However, theoretical concerns include:

Potential interactions with blood-thinning medications, as fatty acid compounds may affect blood clotting, though this has not been specifically documented with CMO. There may also be interactions with immune-suppressing medications, given the proposed immune-modulating effects of cetyl myristoleate.

As with any supplement, it’s important to inform healthcare providers about CMO use, especially before surgeries or when starting new medications. The lack of extensive interaction studies means that unforeseen interactions could occur.

Who should be cautious

Certain groups should exercise particular caution with cetyl myristoleate supplementation:

Pregnant and breastfeeding women should avoid CMO due to lack of safety data in these populations. People with autoimmune conditions should consult healthcare providers, as the immune-modulating effects could potentially interfere with treatment.

Individuals with bleeding disorders or those taking anticoagulant medications should be cautious due to potential effects on blood clotting. People with known allergies to fatty acid compounds or marine-derived substances should also exercise caution.

Frequently asked questions

How long does it take for cetyl myristoleate to work?

Based on limited studies and anecdotal reports, some people report noticing effects within 2-4 weeks of consistent use. However, individual responses vary significantly, and some may not experience noticeable benefits at all.

Is synthetic cetyl myristoleate as effective as natural CMO?

Synthetic CMO is chemically identical to the naturally occurring compound, so there’s no theoretical reason it would be less effective. However, the overall effectiveness of CMO itself remains under investigation.

Can cetyl myristoleate replace conventional arthritis treatments?

No, CMO should not be considered a replacement for proven arthritis treatments. Any changes to arthritis management should be discussed with healthcare providers, and CMO should only be considered as a complementary approach if appropriate.

Are there any quality concerns with CMO supplements?

As with any supplement, quality can vary between manufacturers. Look for products that have been third-party tested for purity and potency, and choose reputable brands that follow good manufacturing practices.

Is cetyl myristoleate suitable for vegetarians and vegans?

Synthetic CMO is not derived from animal sources, making it potentially suitable for vegetarians and vegans. However, individuals should check with manufacturers about production methods and any animal-derived ingredients in the capsules or other components.

Classification:

Typical dose: — · Studied up to: —

References

Authoritative profile & live regulatory status: Cetyl Myristoleate on SupplementIndex →

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
UK Health and Safety Authorities Issue Joint Warning on Asbestos in Consumer Products

UK regulatory authorities issue joint warning on asbestos contamination in imported consumer…

UK Releases Rabies Post-Exposure Risk Assessment Tool for Clinical Practice

The UK Department of Health and Social Care has published a standardised…

UK Sets Minimum Age of 11 for Puberty Blocker Clinical Trial in Gender-Questioning Children

The UK has set a minimum age of 11 years for children…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Propolis

By
Prof. Giorgi Pkhakadze
02/06/2026

Collagen Peptides

By
Prof. Giorgi Pkhakadze
02/06/2026

Casein Protein

By
Prof. Giorgi Pkhakadze
02/06/2026

Digestive Enzymes

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up